University of Utah, John Moran Eye Center
Welcome,         Profile    Billing    Logout  
 7 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bernstein, Paul S
NCT03316300 / 2017-003234-82: A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A

Completed
3
120
Europe, US, RoW
NT-501, Sham Procedure
Neurotech Pharmaceuticals, The Lowy Medical Research Institute Limited
Macular Telangiectasia Type 2 (MacTel)
08/22
09/22
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
SAFE Study, NCT04907084: Serine and Fenofibrate Study in Patients With MacTel Type 2

Active, not recruiting
2
60
Europe, US
Serine, Fenofibrate
The Lowy Medical Research Institute Limited
Macular Telangiectasia Type 2
03/24
03/24
MAGENTA, NCT05265624: The Moran AMD Genetic Testing Assessment Study

Completed
2
76
US
Early disclosure of genetic testing results, Late disclosure of genetic testing results
Paul S. Bernstein
Age-Related Macular Degeneration, Genetic Testing, Nutritional Biomarkers
07/24
07/24
NCT03022773: Macular Pigment Measurements in Eye & Other Tissues

Recruiting
N/A
10000
US
Carotenoid measurements
University of Utah
Macular Pigmentation, Skin Pigment
06/25
06/25
Uni-Rare, NCT05589714: Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

Recruiting
N/A
1500
Europe, Canada, US, RoW
Jaeb Center for Health Research, Foundation Fighting Blindness
Inherited Retinal Degeneration, Retinitis Pigmentosa
12/28
12/28
Moshirfar, Majid
Apricity-B, NCT06100952: Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Recruiting
3
400
US
Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment
Epion Therapeutics
Keratoconus
11/25
11/25
NCT05611294: Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

Active, not recruiting
N/A
42
US
Topography Guided LASIK Surgery, Small Incision Lenticule Extraction Surgery
Hoopes Vision, Alcon Research
Myopia, Astigmatism
05/25
06/25
NCT03319082: Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

Recruiting
N/A
200
US
Corneal Collagen Cross-linking
Glaukos Corporation
Corneal Ectasia
02/26
02/26
Jones, Kaylie
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
Platypus, NCT05902962: SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects

Recruiting
1
20
US
VP-001
PYC Therapeutics
Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11
05/24
05/24
Uni-Rare, NCT05589714: Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

Recruiting
N/A
1500
Europe, Canada, US, RoW
Jaeb Center for Health Research, Foundation Fighting Blindness
Inherited Retinal Degeneration, Retinitis Pigmentosa
12/28
12/28
NCT05573984: Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Recruiting
N/A
50
US, RoW
PYC Therapeutics
Retinitis Pigmentosa, Eye Diseases, Hereditary, Retinal Dystrophies, Retinal Dystrophy Rod, Retinal Dystrophy Rod Progressive
12/26
04/27

Download Options